Empower Clinics Inc said that it has appointed Jennifer Archibald as chief financial officer (CFO) of the company.
The company noted that Archibald joins Empower Clinics' executive team at a critical time as it prepares to enter a phase of hyper-growth and sets its sights on future uplisting. She is a seasoned senior executive with a demonstrated history of working with complex international public and private companies in the healthcare industry and beyond.
"Finding a top-notch finance leader to join as CFO has been a high priority for Empower Clinics as we focus on strengthening our executive team with competencies to grow the business at scale," said Steven McAuley, chairman and CEO of Empower in a statement.
"Her past experiences with Cardiome and The Jim Pattison Group are a great fit for Empower's integrated healthcare and public market vision. Jennifer's broad and branded experience is a perfect match to repeat - and even exceed - what she has successfully done previously for high growth Canadian healthcare companies. I also want to thank Kyle Appleby for his dedicated service as CFO", he added.
READ: Empower Clinics division opens new Medi-Collective clinic co-located with Rexall Pharmacy in Kitchener
The company noted that Archibald brings a breadth of experience in areas such as strategic planning, managing public companies in compliance with securities regulations for Canadian, US and other international exchanges, raising capital, business development, mergers and acquisitions, financial reporting, tax, forecasting, budgeting, internal controls, IT, HR and corporate governance.
Archibald has led high-performing teams across a broad range of industries. As CFO of Cardiome Pharma Corp (TSX:COM), a Vancouver-based, Nasdaq and TSX listed pharmaceutical company with global operations, she was instrumental in completing and integrating a strategic acquisition of a European specialty pharma company in addition to completing multiple corporate partnerships, equity and debt financings totaling more than $250 million.
Prior to Cardiome, Archibald managed the accounting operations of The Jim Pattison Group, a diversified holding company with revenues in excess of $12.5 billion and was a corporate auditor with KPMG. She is a Chartered Professional Accountant (CPA, CA) with a Bachelor of Commerce from The University of British Columbia, Canada.
"The integrated healthcare solutions that the team at Empower Clinics is building is critical to North America's healthcare," commented Archibald. "I see tremendous opportunity in this organization and am incredibly excited to help lead this important next phase of growth for another emerging Vancouver-based healthcare company."
The company also announced that it has granted stock options to officers, employees and consultants to purchase up to a total of 700,000 common shares, exercisable at prices ranging from $0.24 to $0.37 cents per share. The majority of the stock options are exercisable for five years until 2026.
Empower Clinics is an integrated healthcare company that provides body and mind wellness for patients through its clinics, with digital and telemedicine care, a medical device company and world-class medical diagnostics laboratories.
Supported by an experienced leadership team, Empower is aggressively growing its clinical and digital presence across North America. The company's Health & Wellness and Diagnostics & Technology business units are positioned to positively impact the integrated health of its patients, while simultaneously providing long-term value for its shareholders.
Contact the author at jon.hopkins@proactiveinvestors.com